Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms Pseudomonas aeruginosa is a Gram-negative bacterium that is a major cause of hospital-acquired infections, particularly in immunocompromised patients. It is known for its ability to develop resistance to multiple classes of antibiotics, making it a significant therapeutic challenge. This review focuses on the resistance mechanisms of P. aeruginosa, particularly those encoded by its chromosomes, and their regulation. P. aeruginosa has a wide distribution in nature and can be found in various environments, including water, soil, and humans. It is a common commensal organism but can become pathogenic, especially in hospital settings. It is a leading cause of nosocomial infections, including pneumonia, urinary tract infections, and bloodstream infections. The ability of P. aeruginosa to develop resistance to antibiotics is a growing concern, with increasing rates of multidrug-resistant strains. Resistance in P. aeruginosa can arise through several mechanisms, including the acquisition of resistance genes on mobile genetic elements and mutations that alter the expression or function of chromosomally encoded resistance mechanisms. The review discusses the clinical significance of these resistance mechanisms and their complex regulation. Key chromosomally encoded resistance mechanisms in P. aeruginosa include the AmpC cephalosporinase, the OprD outer membrane porin, and multidrug efflux pumps. The AmpC enzyme is involved in resistance to β-lactams, while the OprD porin is crucial for susceptibility to carbapenems. The regulation of these mechanisms is complex and involves multiple pathways, including the induction of AmpC by β-lactams and the derepression of AmpC through mutations in genes such as ampD. The review also discusses the role of other resistance mechanisms, such as the production of β-lactamases and aminoglycoside-inactivating enzymes, which contribute to resistance. The regulation of these mechanisms is influenced by various factors, including the presence of specific genes and the interaction of multiple resistance pathways. The clinical impact of AmpC overproduction is significant, as it can lead to inappropriate antibiotic use and increased mortality. The regulation of AmpC expression involves a complex network of genes and proteins, including AmpR, AmpD, and PBP4. Understanding these mechanisms is crucial for developing strategies to combat antibiotic resistance in P. aeruginosa.Antibacterial-Resistant Pseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms Pseudomonas aeruginosa is a Gram-negative bacterium that is a major cause of hospital-acquired infections, particularly in immunocompromised patients. It is known for its ability to develop resistance to multiple classes of antibiotics, making it a significant therapeutic challenge. This review focuses on the resistance mechanisms of P. aeruginosa, particularly those encoded by its chromosomes, and their regulation. P. aeruginosa has a wide distribution in nature and can be found in various environments, including water, soil, and humans. It is a common commensal organism but can become pathogenic, especially in hospital settings. It is a leading cause of nosocomial infections, including pneumonia, urinary tract infections, and bloodstream infections. The ability of P. aeruginosa to develop resistance to antibiotics is a growing concern, with increasing rates of multidrug-resistant strains. Resistance in P. aeruginosa can arise through several mechanisms, including the acquisition of resistance genes on mobile genetic elements and mutations that alter the expression or function of chromosomally encoded resistance mechanisms. The review discusses the clinical significance of these resistance mechanisms and their complex regulation. Key chromosomally encoded resistance mechanisms in P. aeruginosa include the AmpC cephalosporinase, the OprD outer membrane porin, and multidrug efflux pumps. The AmpC enzyme is involved in resistance to β-lactams, while the OprD porin is crucial for susceptibility to carbapenems. The regulation of these mechanisms is complex and involves multiple pathways, including the induction of AmpC by β-lactams and the derepression of AmpC through mutations in genes such as ampD. The review also discusses the role of other resistance mechanisms, such as the production of β-lactamases and aminoglycoside-inactivating enzymes, which contribute to resistance. The regulation of these mechanisms is influenced by various factors, including the presence of specific genes and the interaction of multiple resistance pathways. The clinical impact of AmpC overproduction is significant, as it can lead to inappropriate antibiotic use and increased mortality. The regulation of AmpC expression involves a complex network of genes and proteins, including AmpR, AmpD, and PBP4. Understanding these mechanisms is crucial for developing strategies to combat antibiotic resistance in P. aeruginosa.